HCP, Inc. (HCP)


NYSE - NYSE Real Time Price. Currency in USD
38.54-0.80 (-2.03%)
At close: 4:02 PM EDT
People also watch:
HCNVTROHIOHR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open39.17
Prev Close39.34
Bid37.00 x 900
Ask39.57 x 2700
Day's Range38.52 - 39.32
52wk Range25.11 - 40.43
1y Target EstN/A
Market Cap18.19B
P/E Ratio (ttm)-267.64
Beta0.26
Volume2,787,881
Avg Vol (3m)3,329,642
Dividend & Yield2.30 (5.93%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • 10 Highest Dividend Stocks on the S&P 500 -- Are Any Worth Buying?
    Motley Fool17 hours ago

    10 Highest Dividend Stocks on the S&P 500 -- Are Any Worth Buying?

    There are stocks on the S&P 500 that pay nearly 10%, but that doesn't make them great investments.

  • American City Business Journalsyesterday

    Big Pharma takes big lease in South S.F. to consolidate California operations

    Drug developer AstraZeneca PLC will bring more than 350 California employees together in the massive Cove at Oyster Point development in South San Francisco, the company said Tuesday. It comes as Big Pharma players, including Merck & Co. Inc., scout local sites in an effort to cozy up to hot, young Bay Area drug developers . The Cove, now in the second phase of construction by HCP Inc. at Highway 101 and Oyster Point Boulevard, already has landed high-profile biotech startups, such as neurodegenerative drug developer Denali Therapeutics Inc. and cancer drug maker CytomX Therapeutics Inc. But AstraZeneca (AZN) could dwarf those companies with its expected fourth-quarter 2017 move-in.

  • Kiplinger2 days ago

    7 High-Dividend Stocks to Buy ASAP

    The Federal Reserve gave the "all clear" to high-dividend stocks when it held off raising rates. Go full steam ahead on these seven.